SpringWorks Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar '25 Mar 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	63.77	69.75	176.05	67.49	103.96	147.09
Short-Term Investments	224.1	238.23	303.15	524.72	269.54	361.4
Cash & Short-Term Investments	287.87	307.99	479.2	592.21	373.5	508.48
Cash Growth	-34.06%	-35.73%	-19.08%	58.56%	-26.55%	55.19%
Receivables	40.35	46.24	5.93	-	-	-
Inventory	12.42	10.21	3.1	-	-	-
Prepaid Expenses	15.68	16.03	12.68	7.55	9.41	4.91
Total Current Assets	356.32	380.47	500.91	599.76	382.91	513.4
Property, Plant & Equipment	25.83	26.66	24.09	18.27	4.2	3.02
Long-Term Investments	94.78	158.12	185.34	8.99	62.11	57.21
Other Intangible Assets	-	15.56	11.2	-	-	-
Other Long-Term Assets	28.43	6.47	4.25	3.23	3.27	2.57
Total Assets	505.36	587.28	725.79	630.24	452.49	576.19
Accounts Payable	14.93	12.25	7.4	8.01	3.43	1.35
Accrued Expenses	65.64	86.01	65.57	39.24	25.38	14.89
Current Portion of Leases	1.7	1.73	1.06	0.48	1.16	1.38
Current Unearned Revenue	-	-	4.14	3.31	-	-
Total Current Liabilities	82.27	99.99	78.17	51.05	29.97	17.61
Long-Term Leases	5.69	6.18	6	4.77	0.13	1.36
Long-Term Unearned Revenue	-	-	15.4	16.23	-	-
Other Long-Term Liabilities	-	-	-	-	-	0.16
Total Liabilities	87.96	106.17	99.57	72.05	30.1	19.13
Common Stock	0.01	0.01	0.01	0.01	0.01	0.01
Additional Paid-In Capital	1,679	1,647	1,524	1,130	715.22	675.62
Retained Earnings	-1,236	-1,153	-895.03	-569.93	-292.51	-118.6
Treasury Stock	-25.45	-12.58	-4.14	-1.34	-	-
Comprehensive Income & Other	0.44	0.3	1.19	-0.77	-0.31	0.04
Total Common Equity	417.4	481.1	626.22	558.19	422.4	557.06
Shareholders' Equity	417.4	481.1	626.22	558.19	422.4	557.06
Total Liabilities & Equity	505.36	587.28	725.79	630.24	452.49	576.19
Total Debt	7.39	7.91	7.06	5.25	1.29	2.73
Net Cash (Debt)	375.26	454.01	655.53	591.76	431.44	559.09
Net Cash Growth	-33.75%	-30.74%	10.78%	37.16%	-22.83%	70.63%
Net Cash Per Share	5.04	6.12	10.38	11.10	8.90	12.91
Filing Date Shares Outstanding	75.32	74.92	73.68	62.28	48.87	48.29
Total Common Shares Outstanding	74.99	74.39	73.38	62.2	48.78	48.13
Working Capital	274.05	280.48	422.74	548.71	352.94	495.79
Book Value Per Share	5.57	6.47	8.53	8.97	8.66	11.57
Tangible Book Value	417.4	465.55	615.02	558.19	422.4	557.06
Tangible Book Value Per Share	5.57	6.26	8.38	8.97	8.66	11.57
Machinery	-	5.93	3.26	0.81	0.52	0.25
Construction In Progress	-	1.79	3.57	7.14	1.97	0.1
Leasehold Improvements	-	3.03	0.83	0.83	1.36	1.18

Updated Mar 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q